Amorphous Solid Dispersion: Improving Dissolution Rate of Poorly Water-Soluble Drug Substance
Research studies show that the majority of API candidates in the development pipeline have a BCS Class II rating, which means those APIs need a solubilization strategy to promote the bioavailability to improve their chance of clinical success.
